• Release date: 1/1/2023

• Expiration date: 12/31/2024

• This enduring activity is Approved for 15 AMA PRA Category 1 Credit(s)™

• Jointly provided by Partners for Advancing Clinical Education (PACE) and CME Science

Educational Objectives

At the conclusion of this activity, participants should better be able to:

• Use contemporary imaging techniques and protocols to accurately diagnose airway disease, lung infection, & mediastinal masses.

• Describe thoracic radiologic procedures for clinical cancer management.

• Outline CT protocols and techniques for improved clinical diagnosis of diseases of the cardiovascular system.

• Integrate information presented in this course into efforts to improve the imaging skills of the participants.

Target Audience

This course is intended for Practicing Radiologists and Radiologic Nurses, Physician Assistants, Technologists, Scientists, Residents, Fellows and others who are interested in current techniques and applications for chest imaging.

Faculty

Charles-White-MD-Icon
Kligerman-MD-Icon-2
Naidich-MD-Icon

Charles S. White, MD

• Professor of Radiology and Internal Medicine
• University of Maryland School of Medicine

 

Seth Kligerman, MD

• Professor of Radiology
• UC San Diego School of Medicine

 

 

David Naidich, MD

• Research Professor, Department of Radiology at NYU Grossman School of Medicine
• Professor Emeritus of Radiology and Medicine, Department of Radiology at NYU Grossman School of Medicine

Course Curriculum

Chest Imaging 2023

Chest Imaging 2023

  1. Lung Cancer Screening on Low Dose CT: Current Status
  2. Imaging of the Solitary Pulmonary Nodule (SPN) Current Status
  3. Missed Lung Cancer and other Thoracic Mishaps
  4. PET CT in Lung Cancer
  5. Imaging of the Mediastinum
  6. Imaging Pulmonary Embolism
  7. The Acute Aortic Syndromes
  8. Fascinating Pulmonary Cases
  9. Coronary CTA: 2022
  10. CTA of the Extracoronary Heart
  11. Myocardial Perfusion/Viability
  12. Pericardium: A Case Review
  13. Diagnosis of the Usual Interstitial Pneumonia (UIP) Pattern on CT
  14. Pulmonary Organization: A Common Response To Injury
  15. Hypersensitivity Pneumonitis and Eosinophilic Pneumonia
  16. Case Review
  17. Emphysema and Cystic Lung Disease: An Algorithmic Approach to Diagnosis
  18. Thoracic Manifestations of Collagen Vascular Diseases
  19. Smoking Related Lung Disease
  20. Mosaic Attenuation Etiologies, Pitfalls, and Methods of Differentiation
  21. Imaging Manifestations of EVALI
  22. Post-Covid Lung Imaging: A Review of Acute Lung Injury, Repair, and Fibrosis
  23. Is it CTEPH? Imaging Features and Mimics
  24. Cases Part II
  25. A Proposed Structural Interstitial CT Approach to Interpreting Multifocal/Diffuse Interstitial Lung Disease
  26. Imaging the Peripheral Airways
  27. CT- Bronchoscopic Diagnostic and Therapeutic Correlations: Central and Peripheral Airways
  28. Incidental Pulmonary Nodules: Current Concepts
  29. Artificial Intelligence: Current Applications to Thoracic Imaging
  30. Claiming Your CME

Pricing

$1450
Chest Imaging 2023
15.0 AMA PRA Category 1 Credit(s)™

Enroll Now

Refund Policy: Cancellations can only be made within 24 hours of purchase. Please note: If you have applied for CME credit during the 24 hour period “NO” refunds will be available. Refunds will be given less a $100.00 administrative fee.

JA

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Partners for Advancing Clinical Education (PACE) and CME Science. Partners for Advancing Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Partners for Advancing Clinical Education (PACE) designates this enduring material for a maximum of 15 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Partners for Advancing Clinical Education (PACE) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PACE policy.  PACE is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Faculty

The faculty members have nothing to disclose.

Planners and Managers

The PACE planners and managers have nothing to disclose. The CME Science planners and managers have nothing to disclose.

Method of Participation and Request for Credit

During the period 1/1/2023 through 12/31/2023, participants must read the learning objectives and faculty disclosures and study the educational activity.

Media

Internet

Computer System Requirements

Any online accessible device.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.